Oncotarget
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases.The term was introduced in the inaugural Editorial,Introducing Oncotarget.
As of January 1, 2022,Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
SSP 47th Annual Meeting
Post-Publication Promotion
Learn about ourFREE
Impact Journals, LLC is the publisher of Oncotarget:www.impactjournals.com.
Impact Journals is a member of theWellcome Trust List of Compliant Publishers.
Impact Journals is a member of theSociety for Scholarly Publishing.
On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control.This malicious action will be reported to the FBI.
Current Volume
This Month's Popular DOIs
(Crossref resolutions)
| 10.18632/ONCOTARGET.23208 |
| 10.18632/ONCOTARGET.6429 |
| 10.18632/ONCOTARGET.9859 |
| 10.18632/ONCOTARGET.13553 |
| 10.18632/ONCOTARGET.14401 |
| 10.18632/ONCOTARGET.15422 |
| 10.18632/ONCOTARGET.16407 |
| 10.18632/ONCOTARGET.19087 |
Most popular Oncotarget DOIs, measured by the number of times each DOI was successfully resolved.
Most Popular DOIs Published in 2024
(Crossref Data)
Top-10 Most Popular DOIs of 2024
(Crossref Data)
Milestones in Modern Scholarly Publishing
On August 25, 2022, the Office of Science and Technology Policy announced a new government policy legislating the immediate public release of all United States-funded research publications by 2025.Learn more here andhere.
On May 23, 2023, the Council of the European Union adopted conclusions on high-quality, transparent, open, trustworthy, and equitable scholarly publishing. The Council calls for immediate and unrestricted open access to publishing research involving public funds.Learn more.
Oncotarget.org: Blog Posts on
New & Trending Papers
Oncotarget.net: Latest Insights
From Our Authors
August 28, 2018
About The Cover
The cover for issue 67 of Oncotarget features Figure 4, "ROC curve analysis of urinary EV mRNA markers in various stages of bladder cancer," byMurakami, et al.
Table of Contents
News
| Rituximab mechanisms of action in B-CLL: a new piece of the puzzle |
https://doi.org/10.18632/oncotarget.26016 Hervé Watier |
| 32732-32733 |
| PDF | How to cite |
| Acquired palbociclib resistance in KRAS-mutant lung cancer |
https://doi.org/10.18632/oncotarget.26027 Charles J. Sherr |
| 32734-32735 |
| PDF | How to cite |
Research Papers
| PKCι and YAP1 are crucial in promoting pancreatic tumorigenesis |
https://doi.org/10.18632/oncotarget.25127 Peipei Wang,Dapeng Wei,Hongmei Zhang,Jiao Chen,Dingding Zhang,Suthakar Ganapathy,Pauline Isakson,Changyan Chen, and Tongbo Zhu |
| 32736-32750 |
| Abstract | PDF | HTML | How to cite |
| A novel, nontoxic iron chelator, super-polyphenol, effectively induces apoptosis in human cancer cell lines |
https://doi.org/10.18632/oncotarget.25973 Toshiaki Ohara,Yasuko Tomono,Xing Boyi,Sun Yingfu,Kazuhiro Omori, and Akihiro Matsukawa |
| 32751-32760 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
| Differential signaling pathway activation in 7,12-dimethylbenz[a] anthracene (DMBA)-treated mammary stem/progenitor cells from species with varying mammary cancer incidence |
https://doi.org/10.18632/oncotarget.25988 Melissa M. Ledet,Meghan Oswald,Robyn Anderson, and Gerlinde R. Van de Walle |
| 32761-32774 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
| PLAGL1 gene function during hepatoma cells proliferation |
https://doi.org/10.18632/oncotarget.25996 Ana F. Vega-Benedetti,Cinthia N. Saucedo,Patrizia Zavattari,Roberta Vanni,Felix Royo,Francisco Llavero,José L. Zugaza, and Luis A. Parada |
| 32775-32794 |
| Abstract | PDF | HTML | How to cite |
| Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance |
https://doi.org/10.18632/oncotarget.25997 Barbara Vizio,Monica Boita,Carmen Cristiano,Jasenka Mazibrada,Ornella Bosco,Anna Novarino,Adriana Prati,Savino Sciascia,Giovanni Rolla,Libero Ciuffreda,Giuseppe Montrucchio, and Graziella Bellone |
| 32795-32809 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
| Bladder cancer detection by urinary extracellular vesicle mRNA analysis |
https://doi.org/10.18632/oncotarget.25998 Taku Murakami,Cindy M. Yamamoto,Tomoshige Akino,Hiroshi Tanaka,Nobuyuki Fukuzawa,Hidetaka Suzuki,Takahiro Osawa,Takahiro Tsuji,Toshimori Seki, and Hiroshi Harada |
| 32810-32821 |
| Abstract | PDF | HTML | Supplementary Information | How to cite | Press Release |
| Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressorCDKN1A in colon cancer cells |
https://doi.org/10.18632/oncotarget.25999 Christian Gerecke,Fabian Schumacher,Alexander Edlich,Alexandra Wetzel,Guy Yealland,Lena Katharina Neubert,Bettina Scholtka,Thomas Homann, and Burkhard Kleuser |
| 32822-32840 |
| Abstract | PDF | HTML | How to cite |
| PAX5A andPAX5B isoforms are both efficient to drive B cell differentiation |
https://doi.org/10.18632/oncotarget.26003 Charlotte Cresson,Sophie Péron,Laura Jamrog,Nelly Rouquié,Nais Prade,Marine Dubois,Sylvie Hébrard,Stéphanie Lagarde,Bastien Gerby,Stéphane J.C. Mancini,Michel Cogné,Eric Delabesse,Laurent Delpy, and Cyril Broccardo |
| 32841-32854 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
| Beyond the 3′UTR binding–microRNA-induced protein truncation via DNA binding |
https://doi.org/10.18632/oncotarget.26023 Melanie von Brandenstein,Stephan H. Bernhart,Andreas Pansky,Claudia Richter,Tobias Kohl,Martina Deckert,Axel Heidenreich,Peter F. Stadler,Manuel Montesinos-Rongen, and Jochen W.U. Fries |
| 32855-32867 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
| Identification of a novel gene fusion in ALT positive osteosarcoma |
https://doi.org/10.18632/oncotarget.26029 Emily Mason-Osann,Anqi Dai,Jess Floro,Ying Jie Lock,Matthew Reiss,Himabindu Gali,Adeline Matschulat,Adam Labadorf, and Rachel Litman Flynn |
| 32868-32880 |
| Abstract | PDF | HTML | Supplementary Information | How to cite |
Corrections
| Correction: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition |
https://doi.org/10.18632/oncotarget.26079 Aroa Baragaño Raneros,Alfredo Minguela,Ramon M. Rodriguez,Enrique Colado,Teresa Bernal,Eduardo Anguita,Adela Vasco Mogorron,Alberto Chaparro Gil,Jose Ramon Vidal-Castiñeira,Leonardo Márquez-Kisinousky,Paula Díaz Bulnes,Amelia Martinez Marin,Maria Carmen García Garay,Beatriz Suarez-Alvarez, and Carlos Lopez-Larrea |
| 32881-32881 |
| Correction | PDF | How to cite |
| Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations inTNFAIP3 followed by mutations inTBL1XR1 andCREBBP |
https://doi.org/10.18632/oncotarget.26080 Hyunchul Jung,Hae Yong Yoo,Seung Ho Lee,Sohyun Shin,Sang Cheol Kim,Sejoon Lee,Je-Gun Joung,Jae-Yong Nam,Daeun Ryu,Jae Won Yun,Jung Kyoon Choi,Ambarnil Ghosh,Kyeong Kyu Kim,Seok Jin Kim,Won Seog Kim,Woong-Yang Park, and Young-Hyeh Ko |
| 32882-32882 |
| Correction | PDF | How to cite |
Copyright © 2025 Rapamycin Press LLC dba Impact Journals